Žiga Skok

713 total citations
17 papers, 444 citations indexed

About

Žiga Skok is a scholar working on Molecular Biology, Toxicology and Organic Chemistry. According to data from OpenAlex, Žiga Skok has authored 17 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Toxicology and 5 papers in Organic Chemistry. Recurrent topics in Žiga Skok's work include Cancer therapeutics and mechanisms (15 papers), Bioactive Compounds and Antitumor Agents (8 papers) and Synthesis and biological activity (4 papers). Žiga Skok is often cited by papers focused on Cancer therapeutics and mechanisms (15 papers), Bioactive Compounds and Antitumor Agents (8 papers) and Synthesis and biological activity (4 papers). Žiga Skok collaborates with scholars based in Slovenia, Hungary and Finland. Žiga Skok's co-authors include Janez Ilaš, D. Kikelj, Nace Zidar, Tihomir Tomašič, Lucíja Peterlin Mašič, Anamarija Zega, Päivi Tammela, Cristina D. Cruz, Martina Durcik and Gábor Draskovits and has published in prestigious journals such as Journal of Medicinal Chemistry, RSC Advances and European Journal of Medicinal Chemistry.

In The Last Decade

Žiga Skok

17 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Žiga Skok Slovenia 11 313 226 88 54 52 17 444
Lyubov G. Dezhenkova Russia 18 417 1.3× 334 1.5× 170 1.9× 75 1.4× 50 1.0× 52 701
Elshimaa M. N. Abdelhafez Egypt 16 255 0.8× 452 2.0× 44 0.5× 68 1.3× 35 0.7× 39 629
Mohamed Alswah Egypt 11 242 0.8× 397 1.8× 54 0.6× 62 1.1× 14 0.3× 13 540
Iveta Zadražilová Czechia 10 179 0.6× 244 1.1× 46 0.5× 25 0.5× 16 0.3× 11 368
Ravikumar Akunuri India 10 224 0.7× 305 1.3× 32 0.4× 39 0.7× 25 0.5× 22 455
Amr Sonousi Egypt 12 197 0.6× 266 1.2× 24 0.3× 28 0.5× 32 0.6× 26 424
Kavitkumar Patel India 11 211 0.7× 214 0.9× 24 0.3× 34 0.6× 41 0.8× 16 447
Akihiko Tanitame Japan 10 230 0.7× 513 2.3× 67 0.8× 43 0.8× 41 0.8× 15 695
Saeed Rajabalian Iran 12 176 0.6× 324 1.4× 41 0.5× 40 0.7× 16 0.3× 19 487
Maryam Nakhjiri Iran 13 161 0.5× 321 1.4× 40 0.5× 54 1.0× 13 0.3× 22 493

Countries citing papers authored by Žiga Skok

Since Specialization
Citations

This map shows the geographic impact of Žiga Skok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Žiga Skok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Žiga Skok more than expected).

Fields of papers citing papers by Žiga Skok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Žiga Skok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Žiga Skok. The network helps show where Žiga Skok may publish in the future.

Co-authorship network of co-authors of Žiga Skok

This figure shows the co-authorship network connecting the top 25 collaborators of Žiga Skok. A scholar is included among the top collaborators of Žiga Skok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Žiga Skok. Žiga Skok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sturtzel, Caterina, Andrea Wenninger-Weinzierl, Asta Zubrienė, et al.. (2024). First dual inhibitors of human topoisomerase IIα and Hsp90 C-terminal domain inhibit the growth of Ewing sarcoma in vitro and in vivo. Bioorganic Chemistry. 153. 107850–107850. 1 indexed citations
2.
Cotman, Andrej Emanuel, Davide Benedetto Tiz, Žiga Skok, et al.. (2024). New N-phenylpyrrolamide inhibitors of DNA gyrase with improved antibacterial activity. RSC Advances. 14(39). 28423–28454. 1 indexed citations
3.
Skok, Žiga, Caterina Sturtzel, Martin Distel, et al.. (2024). Hiding in plain sight: Optimizing topoisomerase IIα inhibitors into Hsp90β selective binders. European Journal of Medicinal Chemistry. 280. 116934–116934. 2 indexed citations
4.
Skok, Žiga, Martina Durcik, Darja Gramec Skledar, et al.. (2023). ATP-competitive inhibitors of human DNA topoisomerase IIα with improved antiproliferative activity based on N-phenylpyrrolamide scaffold. European Journal of Medicinal Chemistry. 249. 115116–115116. 6 indexed citations
5.
Tomašič, Tihomir, Asta Zubrienė, Žiga Skok, et al.. (2021). Selective DNA Gyrase Inhibitors: Multi-Target in Silico Profiling with 3D-Pharmacophores. Pharmaceuticals. 14(8). 789–789. 8 indexed citations
6.
Durcik, Martina, Žiga Skok, Janez Ilaš, et al.. (2020). Hybrid Inhibitors of DNA Gyrase A and B: Design, Synthesis and Evaluation. Pharmaceutics. 13(1). 6–6. 13 indexed citations
7.
Skok, Žiga, Michaela Barančoková, Ondřej Benek, et al.. (2020). Exploring the Chemical Space of Benzothiazole-Based DNA Gyrase B Inhibitors. ACS Medicinal Chemistry Letters. 11(12). 2433–2440. 34 indexed citations
8.
Skok, Žiga, Martina Durcik, Darja Gramec Skledar, et al.. (2020). Discovery of new ATP-competitive inhibitors of human DNA topoisomerase IIα through screening of bacterial topoisomerase inhibitors. Bioorganic Chemistry. 102. 104049–104049. 12 indexed citations
9.
Dobričić, Vladimir, Jelena Grahovac, Siniša Radulović, et al.. (2020). Synthesis and evaluation of anticancer activity of new 9-acridinyl amino acid derivatives. RSC Medicinal Chemistry. 11(3). 378–386. 16 indexed citations
10.
Skok, Žiga, Michaela Barančoková, Lucas Gutiérrez, et al.. (2020). Second-Generation 4,5,6,7-Tetrahydrobenzo[ d ]Thiazoles as Novel DNA Gyrase Inhibitors. Future Medicinal Chemistry. 12(4). 277–297. 11 indexed citations
11.
Fedorowicz, Joanna, Jarosław Sączewski, Agnieszka Konopacka, et al.. (2019). Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents. European Journal of Medicinal Chemistry. 179. 576–590. 67 indexed citations
12.
Tiz, Davide Benedetto, Žiga Skok, Martina Durcik, et al.. (2019). An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors. European Journal of Medicinal Chemistry. 167. 269–290. 42 indexed citations
13.
Cruz, Cristina D., Žiga Skok, Michaela Barančoková, et al.. (2019). Design, synthesis and biological evaluation of novel DNA gyrase inhibitors and their siderophore mimic conjugates. Bioorganic Chemistry. 95. 103550–103550. 14 indexed citations
14.
Skok, Žiga, Tihomir Tomašič, Janez Ilaš, et al.. (2019). Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity. ChemMedChem. 15(3). 265–269. 18 indexed citations
15.
Skok, Žiga, Nace Zidar, D. Kikelj, & Janez Ilaš. (2019). Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets. Journal of Medicinal Chemistry. 63(3). 884–904. 163 indexed citations
16.
Durcik, Martina, Žiga Skok, Cristina D. Cruz, et al.. (2018). New N -phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity. European Journal of Medicinal Chemistry. 154. 117–132. 32 indexed citations
17.
Skok, Žiga, Anita Rácz, Rok Frlan, et al.. (2018). Discovery of d-amino acid oxidase inhibitors based on virtual screening against the lid-open enzyme conformation. Bioorganic & Medicinal Chemistry Letters. 28(10). 1693–1698. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026